Esperion Therapeutics reported $259.49M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 37.16B 1.46B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Cytokinetics CYTK:US USD 609.73M 411.31M
Daiichi Sankyo 4568:JP JPY 101.88B 41.09B
Eli Lilly And LLY:US USD 14.14B 548.2M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Moderna Inc MRNA:US USD 922M 281M
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
United Therapeutics UTHR:US USD 800M 0